跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,351 条关于
“Elevar”
全部
1,351
临床试验
1,202
药物
19
机构
15
资讯
115
去年
Relay Therapeutics and Elevar Therapeutics Announce Licensing Agreement for Lirafugratinib
去年
Elevar Therapeutics Addresses Regulatory Trends and Rivoceranib/Camrelizumab Review
3年前
Elevar Therapeutics Seeks FDA Approval for Rivoceranib and Camrelizumab Combination in Unresectable Hepatocellular Carcinoma
8天前
HLB's Elevar Submits EMA Marketing Application for Lirafugratinib in FGFR2-Driven Cholangiocarcinoma
8天前
Elevar Submits EMA Marketing Authorization Application for Lirafugratinib in FGFR2-Fusion Cholangiocarcinoma
上个月
Elevar Therapeutics to Present Three Abstracts at ESMO 2026, Including Phase 2 THRIVE Trial of Rivoceranib in Thymic Tumors
2年前
Elevar Therapeutics Plans NDA Resubmission for Rivoceranib/Camrelizumab in Unresectable HCC After CRL
去年
FDA Accepts Rivoceranib and Camrelizumab Combination for Liver Cancer
9个月前
Elevar's Rivoceranib-Camrelizumab Combination Shows Significant Survival Benefit in Phase 3 Liver Cancer Trial
2个月前
FDA Issues Complete Response Letter for Elevar's Rivoceranib-Camrelizumab Combination in First-Line HCC
第 1 页,共 12 页
上一页
下一页